Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

TC BioPharm Holdings PLC (TCBP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow TC BioPharm Holdings's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.4800 +0.0500    +3.50%
06:00:29 - Closed. Currency in USD ( Disclaimer )
After Hours
1.4200
-0.0600
-4.0541%
7:56:27 - Real-time Data
  • Volume: 52,007
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 1.4300 - 1.5243
Type:  Equity
Market:  United States
TC BioPharm Holdings 1.4800 +0.0500 +3.50%

TC BioPharm Holdings PLC Company Profile

 
Get an in-depth profile of TC BioPharm Holdings PLC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

60

Equity Type

ORD

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Contact Information

Address Maxim 1 2 Parklands Way
Holytown Motherwell, ML1 4WR
United Kingdom
Phone 44 14 1433 7557
Fax -

Top Executives

Name Age Since Title
Arlene M. Morris 71 2022 Non-Executive Independent Chair
Bryan L. Kobel 42 2021 CEO & Director
Edward Z. Niemczyk 43 2022 Non-Executive Independent Director
James Culverwell 66 2022 Non-Executive Independent Director
Isabelle Riviere - 2022 Member of Scientific Advisory Board
Martin E. Thorp 71 2016 CFO & Director
Mark L. Bonyhadi 70 2022 Chairman of Scientific Advisory Board & Non-Executive Independent Director
Uma Lakshmipathy - 2022 Member of Scientific Advisory Board
Daniel Olive - 2022 Member of Scientific Advisory Board
Blythe Sather - 2022 Member of Scientific Advisory Board
Erin Adams - 2022 Member of Scientific Advisory Board
Chris Bond - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TCBP Comments

Write your thoughts about TC BioPharm Holdings PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email